Medical Condition News

RSS

Patients who survive ICU stay suffer PTSD symptoms, new study finds

Patients who have survived a stay in the intensive care unit (ICU) have a greatly increased risk of developing symptoms of post-traumatic stress disorder (PTSD), according to a new study presented at the 2014 American Thoracic Society International Conference.

19 May 2014

Pharmaceutical and academic leaders come together to discuss biomarkers in ALS

Leaders from academic institutions, non-profit organizations, and pharmaceutical companies will meet in Cambridge, Mass., on Monday, May 19, to discuss biomarkers in amyotrophic lateral sclerosis (ALS).

19 May 2014

Majority of Americans experience foot pain, shows new study

The American Podiatric Medical Association (APMA) today announced the results of its Today's Podiatrist survey, which measures the public's attitudes toward foot health.

19 May 2014

KineMed extends collaboration with CHDI Foundation to track pathogenesis of Huntington's disease

KineMed, Inc. and CHDI Foundation, Inc. announced today an extension of their collaboration that uses KineMed's translational biomarker platform to characterize and track the pathogenesis of Huntington's disease (HD) and evaluate potentially therapeutic interventions.

19 May 2014

Cancer Council urges Queenslanders to get to know their own skin

Cancer Council is urging Queenslanders to get to know their own skin and stay vigilant about early detection, with reports of misdiagnosis for some types of melanoma in the Australasian Journal of Dermatology.

19 May 2014

Registration now open for interactive one day workshop for GPs

Registration is now open for an interactive one day workshop in Brisbane, designed by GPs for GPs, that will cover five hot topics — including statin prescribing and whether the hype is justified on newer oral anticoagulants.

19 May 2014

Ferring launches new interactive website Guts4life for people with IBD

Ferring Pharmaceuticals marks World IBD Day (May 19th) with the launch of Guts4life (www.guts4life.com), a new interactive website with information, support and inspiration for people concerned with Crohn's disease and ulcerative colitis, conditions known as inflammatory bowel diseases (IBD).

19 May 2014

Researcher identify four new microRNAs involved in regulation of BDNF levels

Brain Derived Neurotrophic Factor (BDNF) regulates many processes including memory and learning in our daily tasks.

19 May 2014

Convenient new treatment option for rheumatoid arthritis sufferers offers patient freedom and control of disease

A new subcutaneous formulation of RoActemra® (tocilizumab) has today been launched providing thousands of UK rheumatoid arthritis (RA) patients with a potentially life-changing treatment option.1

19 May 2014

Implantable system improves sleep and heart function without mask

A novel device implanted under the skin like a pacemaker successfully treats central sleep apnoea (CSA) in heart failure patients, according to research presented today at the Heart Failure Congress 2014, held 17-20 May in Athens, Greece.

19 May 2014

ICD, CRT-D patients benefit to almost equivalent extent from home telemonitoring

Home telemonitoring is equally effective in ICD and CRT-D patients, a subanalysis of the IN-TIME trial has shown.

19 May 2014

Birth defects do not appear to be associated with father's semen quality, says study

Birth defects do not appear to be associated with the father's semen quality, according to a new study at the 109th Annual Scientific Meeting of the American Urological Association (AUA).

19 May 2014

Umbian announces outcome of new study for U-Sleep automated messaging system

Umbian Inc., a ResMed (NYSE: RMD) company, and leading provider of cloud-based healthcare compliance solutions, today announced the outcome of a new study that shows significant, measurable efficiency gains when using the automated messaging capabilities of its U-Sleep compliance management solution.

19 May 2014

PARADIGM-HF trial of LCZ696 for chronic heart failure stopped early for benefit

The PARADIGM-HF trial has been stopped early for a benefit to patients that was overwhelmingly statistically significant.

19 May 2014

Phase III INPULSIS trials show nintedanib slows disease progression in patients with IPF

Results from the Phase III INPULSIS™ trials, published online today in the New England Journal of Medicine, show nintedanib significantly slowed disease progression in patients with idiopathic pulmonary fibrosis (IPF).

19 May 2014

FibroGen’s Phase 2a study supports safety and efficacy of FG-3019 in IPF patients

FibroGen, Inc. (FibroGen) announced today the presentation of clinical data at the American Thoracic Society (ATS) International Conference supporting the safety and efficacy of FG-3019 in patients with idiopathic pulmonary fibrosis (IPF), a debilitating and life-threatening lung disease for which there is currently no approved therapy in the United States.

19 May 2014

TEVA presents results from real-life, observational study of QVAR at ATS 2014 International Conference

Teva Pharmaceutical Industries Ltd., (NYSE: TEVA) today announced that results from a real-life, retrospective, observational study of QVAR- will be presented at the American Thoracic Society (ATS) 2014 International Conference in San Diego on May 18, 2014.

19 May 2014

Study shows technology improves transition into adulthood for adolescents with chronic disease

Adolescents with chronic diseases (ACD), such as cystic fibrosis, gastrointestinal disorders (including Crohn's disease) and Type 1 diabetes, often find the transition of managing their health care needs into adulthood to be challenging.

19 May 2014

Study finds increased risk of hospitalization for heart failure in IBD patients

Heart failure hospitalisation more than doubles during inflammatory bowel disease (IBD) flares, according to a study of more than 5 million Danish people. The research was presented today at the Heart Failure Congress 2014, held 17-20 May, in Athens, Greece.

19 May 2014

Vitamin D shown to have limited benefit for asthma

Adding vitamin D to asthma treatment to improve breathing only appears to benefit patients who achieve sufficient levels of the supplement in the blood. Overall, the ability to control asthma did not differ between a study group that received vitamin D supplements and a group that received placebo, according to new research at Washington University School of Medicine in St. Louis.

19 May 2014

Medical Condition News

Patients who survive ICU stay suffer PTSD symptoms, new study finds

Pharmaceutical and academic leaders come together to discuss biomarkers in ALS

Majority of Americans experience foot pain, shows new study

KineMed extends collaboration with CHDI Foundation to track pathogenesis of Huntington's disease

Cancer Council urges Queenslanders to get to know their own skin

Registration now open for interactive one day workshop for GPs

Ferring launches new interactive website Guts4life for people with IBD

Researcher identify four new microRNAs involved in regulation of BDNF levels

Convenient new treatment option for rheumatoid arthritis sufferers offers patient freedom and control of disease

Implantable system improves sleep and heart function without mask

ICD, CRT-D patients benefit to almost equivalent extent from home telemonitoring

Birth defects do not appear to be associated with father's semen quality, says study

Umbian announces outcome of new study for U-Sleep automated messaging system

PARADIGM-HF trial of LCZ696 for chronic heart failure stopped early for benefit

Phase III INPULSIS trials show nintedanib slows disease progression in patients with IPF

FibroGen’s Phase 2a study supports safety and efficacy of FG-3019 in IPF patients

TEVA presents results from real-life, observational study of QVAR at ATS 2014 International Conference

Study shows technology improves transition into adulthood for adolescents with chronic disease

Study finds increased risk of hospitalization for heart failure in IBD patients

Vitamin D shown to have limited benefit for asthma

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News